Elif Ayça Şahin | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Elif Ayça Şahin
Gazi University Faculty of Medicine, Turkey

Elif Ayça Şahin
Affiliation Gazi University Faculty of Medicine
Country Turkey
Scopus ID 57548691200
Documents 28
Citations 44
h-index 4
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0002-2215-2756

The Innovative Research Award recognizes researchers whose scholarly activities contribute to the advancement of scientific knowledge through original investigations, peer-reviewed publications, and measurable research impact. Elif Ayça Şahin of Gazi University Faculty of Medicine has established a documented record of scientific contributions within medicine and health sciences, particularly through studies addressing infectious diseases, microbiology, molecular biology, respiratory health, and translational biomedical research. Her publication portfolio demonstrates engagement with contemporary healthcare challenges and emerging diagnostic methodologies.[1]

Abstract

This academic recognition article presents a scholarly overview of Elif Ayça Şahin’s research activities, publication record, and scientific contributions in medicine and health sciences. The profile highlights peer-reviewed publications focused on infectious diseases, fungal diagnostics, respiratory viral epidemiology, molecular mechanisms of disease, and translational biomedical investigations. Through a combination of laboratory-based and clinically relevant studies, the researcher has contributed to expanding knowledge in diagnostic microbiology, public health surveillance, and molecular medicine. The documented publication portfolio and citation metrics support consideration for the Innovative Research Award within the International Forensic Scientist Awards framework.[1]

Keywords

Medicine, Health Sciences, Infectious Diseases, Molecular Biology, Clinical Microbiology, Respiratory Viruses, Fungal Diagnostics, Translational Research, Biomedical Science, Scientific Publications.

Introduction

Modern biomedical research increasingly relies on interdisciplinary approaches that connect laboratory investigations with clinical applications. Researchers operating within this environment contribute to improved diagnostic accuracy, disease monitoring, therapeutic development, and evidence-based healthcare decision-making. Elif Ayça Şahin’s body of work reflects participation in this evolving scientific landscape through investigations addressing infectious pathogens, molecular pathways, fungal diseases, and epidemiological trends affecting patient care.[2]

Research Profile

Elif Ayça Şahin is affiliated with Gazi University Faculty of Medicine, Turkey. According to Scopus-indexed records, the researcher has authored 28 scholarly documents with 44 citations and an h-index of 4. The research portfolio spans medicine and health sciences with emphasis on infectious disease diagnostics, microbiology, immunological responses, respiratory viral infections, and molecular mechanisms associated with disease progression. The published literature demonstrates engagement with both experimental and clinically oriented investigations that contribute to the broader understanding of human health and disease.[1]

Research Contributions

  • Investigation of autophagy-related molecular pathways and microRNA regulation in experimental disease models.[2]
  • Development and evaluation of fungal screening methodologies for diagnostic applications in clinical microbiology.[3]
  • Comparative studies examining fungal survival characteristics across environmental surfaces relevant to infection control.[4]
  • Systematic review contributions addressing rare fungal infections and associated clinical outcomes.[5]
  • Retrospective analyses exploring respiratory virus prevalence, immune status, and co-detection patterns in healthcare settings.[6]

Publications

  1. Inhibition of miR-106a/b Modulates Autophagy-Related Gene Expression in the ULK1–Beclin-1–ATG12 Axis in Experimental Colitis. Bratislava Medical Journal (2026).
  2. Preliminary evaluation of a SYBR Green-based screening approach for selected fungal targets in simulated cerebrospinal fluid samples. Journal of Health Sciences and Medicine (2026).
  3. Candidozyma (Candida) auris’in Farklı Yüzeylerdeki Canlılık Süresi: Diğer Candida Türleriyle Karşılaştırmalı Bir In Vitro Çalışma. Flora the Journal of Infectious Diseases and Clinical Microbiology (2026).
  4. Meningitis caused by Candida dubliniensis in a patient with meningioma: a systematic review of the literature. Irish Journal of Medical Science (2026).
  5. Impact of immune status on respiratory virus prevalence and co-detection patterns: a retrospective analysis (2019–2024). BMC Pulmonary Medicine (2026).

Research Impact

The available publication and citation indicators demonstrate a developing research profile supported by peer-reviewed scientific output and measurable scholarly engagement. Research activities encompass both experimental investigations and clinically relevant analyses, facilitating knowledge generation in microbiology, infectious disease research, and molecular medicine. Citation activity and indexed publications indicate dissemination within the international scientific community and contribute to evidence-based healthcare research.[1]

Award Suitability

The Innovative Research Award recognizes individuals whose research demonstrates originality, scientific rigor, and meaningful contribution to their discipline. Based on the documented publication record, involvement in contemporary biomedical research topics, and contributions to infectious disease diagnostics and molecular investigations, Elif Ayça Şahin meets several scholarly characteristics associated with research excellence. The diversity of recent publications and continued engagement with emerging healthcare challenges support consideration for recognition within the International Forensic Scientist Awards program.[2][6]

Conclusion

Elif Ayça Şahin has contributed to medicine and health sciences through research addressing molecular biology, infectious diseases, fungal diagnostics, and respiratory health. The scholarly record reflects participation in peer-reviewed research, interdisciplinary collaboration, and the dissemination of scientific findings through recognized journals. These achievements collectively demonstrate a research profile aligned with the objectives of the Innovative Research Award and the broader mission of promoting scientific advancement and innovation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Elif Ayça Şahin, Author ID 57548691200. Scopus.
    https://www.scopus.com/pages/authors/57548691200
  2. Şahin EA, et al. (2026). Inhibition of miR-106a/b Modulates Autophagy-Related Gene Expression in the ULK1–Beclin-1–ATG12 Axis in Experimental Colitis. Bratislava Medical Journal.
    https://doi.org/10.1007/s44411-026-00796-8
  3. Şahin EA, et al. (2026). Preliminary evaluation of a SYBR Green-based screening approach for selected fungal targets in simulated cerebrospinal fluid samples. Journal of Health Sciences and Medicine.
    https://doi.org/10.32322/jhsm.1937982
  4. Şahin EA, et al. (2026). Candidozyma (Candida) auris’in Farklı Yüzeylerdeki Canlılık Süresi. Flora the Journal of Infectious Diseases and Clinical Microbiology.
    https://doi.org/10.5578/flora.2026021525
  5. Şahin EA, et al. (2026). Meningitis caused by Candida dubliniensis in a patient with meningioma. Irish Journal of Medical Science.
    https://doi.org/10.1007/s11845-026-04433-9
  6. Şahin EA, et al. (2026). Impact of immune status on respiratory virus prevalence and co-detection patterns: a retrospective analysis (2019–2024). BMC Pulmonary Medicine.
    https://doi.org/10.1186/s12890-026-04310-2

Mohammad El Garhy | Medicine and Health Sciences | Best Innovation Award

Published on by Forensic Scientist Awards

Best Innovation Award

Mohammad El Garhy
Researcher Mohammad El Garhy
Affiliation Department of Internal Medicine I, Cardiology, University Hospital Jena
Country Germany
Scopus ID 57192109926
Documents 19
Citations 219
h-index 5
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0002-8578-0135

Mohammad El Garhy
Department of Internal Medicine I, Cardiology, University Hospital Jena, Germany

The Best Innovation Award recognizes scholarly contributions demonstrating scientific originality, translational relevance, and measurable impact within their respective disciplines. Mohammad El Garhy is a cardiology researcher whose academic work emphasizes structural heart disease, transcatheter cardiovascular interventions, multimodality imaging, and minimally invasive diagnostic technologies. His publications reflect continued participation in collaborative clinical research concerning transcatheter valve therapies, cardiovascular imaging, and interventional cardiology, contributing to evidence-based improvements in patient management.[1]

Abstract

Mohammad El Garhy has developed a publication record focused on interventional cardiology, cardiovascular imaging, and catheter-based structural heart interventions. His research addresses clinically important topics including transcatheter aortic valve implantation, MitraClip therapy, computed tomography-based valve assessment, and the expanding role of endoscopic ultrasound in cardiovascular diagnosis. These investigations contribute to improved procedural planning and patient outcomes while supporting innovation in minimally invasive cardiovascular medicine.[2]

Keywords

  • Interventional Cardiology
  • Transcatheter Valve Therapy
  • Cardiovascular Imaging
  • Structural Heart Disease
  • Medical Innovation

Introduction

Advances in structural heart interventions increasingly depend upon precise imaging, multidisciplinary clinical decision-making, and minimally invasive therapeutic strategies. Mohammad El Garhy’s scholarly work aligns with these developments by examining diagnostic technologies and transcatheter procedures that support evidence-based cardiovascular care. His publications have appeared in peer-reviewed journals dedicated to clinical cardiology and cardiovascular interventions.[3]

Research Profile

According to the supplied academic metrics, Mohammad El Garhy has authored 19 indexed publications with 219 citations and an h-index of 5. His primary research interests include transcatheter aortic valve implantation, mitral valve repair, computed tomography assessment of valvular disease, endoscopic ultrasound applications, and cardiovascular intervention planning.[1]

Research Contributions

  • Evaluation of transcatheter mitral valve repair outcomes.
  • Clinical assessment of porcelain aorta during TAVI procedures.
  • Studies comparing CT-based aortic valve calcium quantification methods.
  • Investigation of endoscopic ultrasound for cardiovascular diagnosis and intervention.
  • Clinical analyses supporting minimally invasive structural heart therapies.

Publications

  • The Role of Endoscopic Ultrasound in Cardiology (2026).
  • Impact of Porcelain Aorta on Outcomes in TAVI (2025).
  • Transcatheter Mitral Valve Repair via MitraClip (2023).
  • Contemporary Results of Transcatheter Mitral Valve Procedures (2022).
  • Aortic Valve Calcium Volume Assessment in TAVR Patients (2022).

Research Impact

The available publication record demonstrates continuing engagement in clinically relevant cardiovascular research. Studies addressing procedural optimization, diagnostic imaging, and structural heart interventions provide evidence that may support future improvements in patient care, multidisciplinary practice, and minimally invasive cardiovascular medicine.[4]

Award Suitability

Based on the documented publication record, research metrics, and emphasis on innovative cardiovascular diagnostics and interventions, Mohammad El Garhy’s scholarly activities demonstrate characteristics commonly considered during evaluations for innovation-oriented academic recognition. Award decisions remain dependent upon the official selection criteria established by the organizing committee.[5]

Conclusion

Mohammad El Garhy has contributed to contemporary cardiovascular medicine through investigations involving structural heart disease, catheter-based interventions, and advanced imaging. His research portfolio reflects ongoing participation in clinically significant studies that support evidence generation and innovation within interventional cardiology.

References

  1. Elsevier. Scopus Author Details: Mohammad El Garhy, Author ID 57192109926.
    https://www.scopus.com/authid/detail.uri?authorId=57192109926
  2. El Garhy M. The Role of Endoscopic Ultrasound in Cardiology. Journal of Clinical Medicine (2026). DOI:
    https://doi.org/10.3390/jcm15135006
  3. Open Heart. Impact of Porcelain Aorta on Outcomes in TAVI.
    https://doi.org/10.1136/openhrt-2024-003069
  4. Interventional Cardiology. Transcatheter Mitral Valve Repair via MitraClip.
    https://doi.org/10.15420/icr.2021.28
  5. The Egyptian Heart Journal. Contemporary Results of Transcatheter Mitral Valve Procedures.
    https://doi.org/10.1186/s43044-022-00257-x

Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Damascus University | Syria

Dr. Rama Ayash is a medical advisor, senior lecturer, and scientific researcher specializing in clinical biochemistry, diabetes research, and molecular mechanisms of β-cell apoptosis. Her primary research focuses on the pathophysiological role of cytokines and death receptors in glucose dysregulation and prediabetes, with particular emphasis on the therapeutic effects of DPP4 inhibitors such as sitagliptin. Her recent publications include groundbreaking studies in Scientific Reports, BMC Endocrine Disorders, and the European Journal of Pharmacology, exploring inflammatory cytokine modulation, apoptotic biomarkers (FAS, TNFR1, TRAIL-R2), and their relationship to β-cell dysfunction. Dr. Rama Ayash’s research contributions advance understanding of early diabetic mechanisms, aiding in the development of targeted therapeutic strategies to preserve pancreatic function. She has also supervised diverse clinical and molecular research projects in cardiovascular pharmacology, endocrine biomarkers, and celiac disease diagnostics, demonstrating her interdisciplinary expertise. Her work integrates clinical biochemistry, molecular diagnostics, and translational medicine, contributing to the growing field of preventive and precision diabetology. Dr. Rama Ayash has been an active conference speaker and scientific presenter, sharing insights on cardio-renal pharmacology, metabolic pathways, and biomarker discovery. Her continuing research endeavors aim to bridge laboratory findings with clinical outcomes to enhance diagnostic accuracy and therapeutic efficacy in metabolic diseases.

Profiles: Google Scholar | ORCID

Featured Publications

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Exploring the predictive potentials of IL-1β and TNFR1 in atherogenic risk in prediabetes. Scientific Reports, 15(1), 37369. https://doi.org/10.1038/s41598-025-37369

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Association of soluble apoptotic biomarkers (FAS, TNFR1 and TRAIL-R2) with β-cell dysfunction in early glucose dysregulation. BMC Endocrine Disorders, 25(1), 218. https://doi.org/10.1186/s12902-025-0218

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Sitagliptin reduces cytokine-induced β-cell apoptosis in prediabetes: A six-month interventional study. European Journal of Pharmacology, 177708. https://doi.org/10.1016/j.ejphar.2025.177708

Chunmei Qin | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Chunmei Qin | Medicine and Health Sciences | Best Researcher Award

Luzhou People’s Hospital | China

Dr. Chunmei Qin is a highly respected nephrologist and Director at Luzhou People’s Hospital. With over a decade of dedicated experience in clinical practice, research, and academic mentoring, she has played a pivotal role in advancing nephrology care in China. Her scientific acumen and leadership have led her to spearhead more than ten provincial and municipal research initiatives, gaining national recognition for her innovative contributions. As a recipient of multiple prestigious honors, she exemplifies clinical excellence blended with research-driven impact.

Author Profile👤

Scopus

Strengths for the Awards✨

Dr. Chunmei Qin brings over a decade of comprehensive clinical, academic, and research experience in nephrology, making her a competitive candidate for the Best Researcher Award. She has led or participated in 10+ provincial and municipal-level research projects, including those funded by the Luzhou Medical Association, Sichuan Province Medical Research Project Plan, and Luzhou Science and Technology Program. Notably, one of her research outcomes has been recognized as nationally advanced.

She has authored five peer-reviewed articles in respected SCI-indexed journals, with research that spans from kidney failure in diabetic nephropathy patients to oxidative stress mechanisms in diabetic kidney disease. These works contribute meaningfully to both clinical practice and academic discourse. Additionally, she has received multiple accolades, including:

  • Outstanding Young Paper Award by the Sichuan Medical Association.

  • Outstanding Contribution Award by the Municipal Health Commission.

Her active engagement in professional organizations and committees (such as the Nephropathy Branch of the Sichuan Medical Promotion Association) further reinforces her leadership in the field.

🎓 Education

Dr. Qin holds a strong academic foundation in nephrology, built through extensive medical training and continuous professional development. Her academic journey is characterized by a focus on integrating clinical insights with evidence-based research, equipping her with the analytical skills and expertise required to navigate complex patient cases and contribute to impactful studies.

🏥 Experience

Currently serving as Director at Luzhou People’s Hospital, Dr. Qin has amassed significant experience across clinical care, research, and medical education. Her responsibilities encompass managing nephrology units, mentoring junior physicians, and leading interdisciplinary teams in patient-centered care. Her experience extends beyond the bedside to include policymaking contributions at the municipal level through health commissions.

🔬 Research Interests On Medicine and Health Sciences

Dr. Qin’s research interests lie primarily in nephrology, with a special focus on diabetic kidney disease, chronic kidney failure, oxidative stress mechanisms, and the psychological implications of kidney disease. She is passionate about exploring the intersection between metabolic disorders and renal complications, as well as applying molecular approaches to improve patient outcomes.

🏆 Awards

Dr. Qin has received multiple accolades in recognition of her outstanding contributions. These include the Outstanding Young Paper Award from the Sichuan Medical Association and the Outstanding Contribution Award from the Municipal Health Commission. Her work, acknowledged both locally and nationally, reflects her commitment to excellence in nephrology research and healthcare delivery.

📄 Publications

Dr. Qin has authored several impactful studies in internationally recognized SCI journals, demonstrating both breadth and depth in her research:

  1. Qin, C., Wu, Y., Zou, Y., et al. Associations between depressive and anxiety symptoms and incident kidney failure in patients with diabetic nephropathy, BMC Nephrology, 2025; 26:54. Cited by multiple nephrology scholars for its clinical relevance.

  2. Qin, C., Wang, Y., Zhao, L., et al. Clinical and pathological features of Chinese patients with type 2 diabetes, biopsy-proven diabetic kidney disease, and rapid eGFR decline, Diabetes Metab Syndr Obes, 2022; 15:2847–2856. Widely cited for advancing understanding of kidney function trajectories.

  3. Qin, C., Yin, D., Liu, F., et al. Thrombotic thrombocytopenic purpura in a patient on long-term alpha-interferon therapy: a case report, BMC Nephrology, 2023; 24(1):143. Referenced in case studies on rare renal pathologies.

  4. Zhang, R., Qin, C., Zhang, J., et al. DNA hypomethylation of Syk induces oxidative stress and apoptosis via the PKCβ/P66shc pathway in diabetic kidney disease, FASEB Journal, 2024; 38(6):e23564. Significantly cited in molecular nephrology and oxidative stress research.

  5. Qin, C., Li, G., Yuan, Y., et al. Association between uric acid to HDL-C ratio and diabetic kidney disease in US adults, Scientific Reports, 2025; 15:24353. Cited for its epidemiological insights on metabolic markers.

Zhanbo Qu | Medicine | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Zhanbo Qu | Medicine | Best Researcher Award

Huzhou central hospital | China

Dr. Qu Zhanbo is a dedicated medical professional at Huzhou Central Hospital, with a focus on microbiology, oncology, and gastroenterology. As a researcher, Dr. Qu has made significant contributions to the scientific community, publishing multiple papers in esteemed journals. His academic journey is marked by exceptional achievements, including being recognized as a top graduate innovative talent during his master’s studies.

Professional profile👤

ORCID

Strengths for the Awards✨

  • Research Productivity: Qu Zhanbo has published 2 SCI papers as the first author, 3 SCI papers as a total of first author, and contributed to 16 SCI papers overall. This demonstrates consistent research output and collaboration.

  • Interdisciplinary Focus: His research spans microbiology, oncology, and gastroenterology — fields with significant impact on healthcare, especially in understanding colorectal cancer risk.

  • Recognition and Innovation: Awarded as a top graduate Innovative Talent during his master’s studies, reflecting early recognition for his research potential.

  • Patent Development: Involved in the development of dissolving microneedles of Clostridium butyricum and oxaliplatin, indicating a focus on translational research and innovation.

  • Diverse Publications: Contributions to reputable journals like Aging and Disease, Aging-US, Digestion, and Microbial Biotechnology highlight his research’s acceptance in well-regarded scientific communities.

Education 🎓

Dr. Qu Zhanbo pursued his medical education with a deep interest in understanding complex diseases and their microbial interactions. His academic path laid the foundation for his subsequent research endeavors, where he explored the intersection of microbiology and oncology.

Experience 💼

Currently serving at Huzhou Central Hospital, Dr. Qu combines clinical practice with groundbreaking research. His work spans various domains, including the association of Peptostreptococcus stomatis with colorectal cancer risk. Over the years, he has authored multiple SCI papers and contributed extensively to scientific literature, showcasing his expertise and commitment to advancing medical knowledge.

Research Interests On Medicine🔬

Dr. Qu’s research interests lie at the crossroads of microbiology, oncology, and gastroenterology. His investigations delve into microbial influences on cancer development, aiming to uncover novel insights that could lead to improved diagnostic and therapeutic strategies.

Awards 🏆

Dr. Qu’s academic and research excellence have been recognized through several accolades, including being awarded as a top graduate innovative talent during his master’s studies. This honor reflects his exceptional contributions to scientific inquiry and innovation.

Publications 📖

Dr. Qu has an impressive publication record, with notable papers such as:

  1. Multiple primary malignancies and gut microbiome

    • Year: 2025

    • Authors: Yinhang Wu, Zhanbo Qu, Zheng Wu, Jing Zhuang, Yingchen Wang, Zefeng Wang, Jian Chu, Quan Qi, Shuwen Han

  2. Fecal occult blood affects intestinal microbial community structure in colorectal cancer

    • Year: 2025

    • Authors: Wu Guodong, Wu Yinhang, Wu Xinyue, Shen Hong, Chu Jian, Qu Zhanbo, Han Shuwen

  3. Aging Gut Microbiome in Healthy and Unhealthy Aging

    • Year: 2024

    • Authors: Zhanbo Qu

  4. Classification of Colorectal Cancer Subtypes Based on Endoplasmic Reticulum Stress

    • Year: 2024

    • Authors: Zhanbo Qu, Jian Chu, Yinhang Wu, Jing Zhuang, Jiang Liu, Shugao Han, Wei Wu, Shuwen Han

  5. Escherichia coli on colorectal cancer: A two‐edged sword

    • Year: 2024 (October)

    • Authors: Chu Jian, Wu Yinhang, Zhuang Jing, Qu Zhanbo, Wang Zefeng, Shuwen Han

  6. Deep learning application in prediction of cancer molecular alterations based on pathological images: a bibliographic analysis via CiteSpace

    • Year: 2024 (October)

    • Authors: Yu Xiaojian, Qu Zhanbo, Chu Jian, Wang Zefeng, Liu Jian, Liu Jin, Pan Yuefen, Han Shuwen

  7. Third-generation PacBio sequencing to explore gut bacteria and gender in colorectal cancer

    • Year: 2024 (July)

    • Authors: Sheng Yu, Jian Chu, Yinhang Wu, Jing Zhuang, Zhanbo Qu, Yifei Song, Xinyue Wu, Shuwen Han

  8. Age and aging process alter the gut microbes

    • Year: 2024 (April 8)

    • Authors: Qu Zhanbo, Zhuang Jing, Han Shugao, Wu Yinhang, Chu Jian, Yu Xiang, Zhao Feimin, Liu Jian, Wu Xinyue, Wu Wei et al.

  9. Transcriptional profile and immune infiltration in colorectal cancer reveal the significance of inducible T‐cell costimulator as a crucial immune checkpoint molecule

    • Year: 2024 (March)

    • Authors: Jian Chu, Yinghang Wu, Zhanbo Qu, Jing Zhuang, Jiang Liu, Shugao Han, Wei Wu, Shuwen Han

  10. Identification of enterotype and its predictive value for patients with colorectal cancer

  • Year: 2024 (February 27)

  • Authors: Li Qingbo, Zhuang Jing, Qu Zhanbo, Chu Jian, Song Yifei, Wu Yinhang, Han Shuwen

Conclusion 🔝

Dr. Qu Zhanbo stands out as a passionate researcher and dedicated doctor whose work bridges clinical practice and scientific exploration. His contributions to microbiology, oncology, and gastroenterology continue to shape the understanding of disease mechanisms and pave the way for future innovations in medical science.